Liquidia (LQDA) Shares Outstanding (Entity) (2019 - 2026)
Liquidia (LQDA) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 414.15 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 42.68 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.15 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 101.60 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 499.55 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 834.66 Mn |
| 10 | Liquidia | 6.09 Bn | 5.80 Bn | 160.92 Mn | 89.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 89.10 Mn |
| Mar 31, 2026 | 88.31 Mn |
| Dec 31, 2025 | 87.20 Mn |
| Sep 30, 2025 | 86.82 Mn |
| Jun 30, 2025 | 85.86 Mn |
| Mar 31, 2025 | 85.30 Mn |
| Dec 31, 2024 | 84.68 Mn |
| Sep 30, 2024 | 84.55 Mn |
| Jun 30, 2024 | 76.41 Mn |
| Mar 31, 2024 | 76.29 Mn |
| Dec 31, 2023 | 68.63 Mn |
| Sep 30, 2023 | 64.90 Mn |
| Jun 30, 2023 | 64.74 Mn |
| Mar 31, 2023 | 64.71 Mn |
| Dec 31, 2022 | 64.52 Mn |
| Sep 30, 2022 | 64.46 Mn |
| Jun 30, 2022 | 64.35 Mn |
| Mar 31, 2022 | 53.05 Mn |
| Dec 31, 2021 | 52.29 Mn |
| Sep 30, 2021 | 51.98 Mn |